KGJI [KINGOLD JEWELRY] DEFA14A: (Original Filing)
[]
KGJI [KINGOLD JEWELRY] 8-K: (Original Filing)
[Party A: Address: Room 1304, Junan Apartment, Dongting Street, Jiang’an District, Wuhan Party B: Address: Te No. 15, Huangpu Science Park, Jiang’an District, Wuhan Whereas: Acquisition Agreement rd 1. Party B signed Acquisition Agreement 2. According to the aforementioned Acquisition Agreement 3. According to the aforementioned 4. At present, Party B has paid a total of RMB 640 million for] [Office Lease Lessor (Party A): Wuhan Huayuan Technology Development Co., Ltd. Lessee (Party B): Wuhan Kingold Jewelry Co., Ltd. According to the rules of Contract Law of our nation and the relevant laws and regulations, the following contract relevant with the building leasing should be established on the basis of equality, free will and consensus by negotiation: Article 1 Premises] [The Store Lease Lessor (Party A): Wuhan Huayuan Technology Development Co., Ltd. Lessee (Party B): Wuhan Kingold Jewelry Co., Ltd. According to the rules of Contract Law of our nation and the relevant laws and regulations, the following contract relevant with the building leasing should be established on the basis of equality, free will and consensus by negotiation: Article 1] [KINGOLD JEWELRY SELLS JEWELRY PARK FOR APPROXIMATELY $171 MILLION Company will Focus on Expansion of its Core Jewelry Business; Will Relocate Its Headquarters to the Jewelry Park WUHAN CITY, China, July 29, 2016 - Kingold Jewelry, Inc. ("Kingold" or "the Company") (NASDAQ: KGJI), Wuhan Kingold Wuhan Lianfuda has paid Background on Development of the Jewelry Park Before the Transfer Contract] []
KANG [iKang Healthcare] 20-F: (Original Filing)
[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report. . . . . . . . . . . . . . . . . . . . For the transition period from to iKang Healthcare Group, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) B-6F, Shimao Tower 92A] [New China Life Insurance Co., Ltd. (NCI), iKang Guobin Healthcare Group Co., Ltd. (iKang), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (Top Spring Pu Chang) and New China Life Insurance Health Investment Management Co., Ltd. (the Target Company) entered into the Capital Injection Agreement (the Agreement) on December 4, 2015, as supplemented by the Supplemental Agreement to the] [iKang Healthcare Technology Group Co., Ltd. (the Borrower) and AVIC Trust Co., Ltd. (the Lender) entered into the Loan Agreement (the Agreement) on December 9, 2015. Article 1. The Loan Amount The amount of loan (Loan) hereunder is RMB500,000,000. Article 2. Usage of the Loan. 2.1 2.2 Article 3. Term of the Loan. 3.1 3.2 1 3.3 3.4 3.5 3.6] [Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (Party A) and iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) (i) 1] [Zhongjin Zhide Equity Investment Management Co., Ltd. (Party A) and iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) entered into the Investment Agreement on December 11, 2015. Article 1. Terms of Loan and Conversion (1) (2) (3) (4) (5) 1 (i) (ii) (1) (2) (3) (4) 2 (5) Article 4. Event of Default (1) (2) (3) (4)] [Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (Party A), iKang Healthcare Technology Group Co., Ltd. (Party B, or the Company) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (Party C) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016. Article 1. Terms of] [List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong Medifast (Hong Kong) Ltd. (Causeway Bay Branch) Hong Kong Medifast (Hong Kong) Ltd. (Kowloon Branch)] [I, Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 2016 EX-13.1 10 a16-11673_1ex13d1.htm EX-13.1] [Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 29, 201 EX-13.2 11 a16-11673_1ex13d2.htm EX-13.2] [15.1 29 July, 2016 Matter No.:823187 Doc Ref: 102708437 +852 2842 9531 Anna.Chong@conyersdill.com Charissa.Ball@conyersdill.com The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the Company) Form 20-F Yours faithfully, EX-15.1 12 a16-11673_1ex15d1.htm EX-15.1] [July 29, 2016 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Ladies and Gentlemen, We consent to the reference to our firm under the captions of Item 3.D Risk Factors and Item 4.C Organizational Structure in iKang Healthcare Group, Inc.s annual report on Form 20-F for the year] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-197289 and Beijing, the Peoples Republic of China July 29, 2016 EX-15.3 14 a16-11673_1ex15d3.htm EX-15.3]
EFUT [eFuture] 6-K: (Original Filing)
[eFuture Announces Unaudited Second Quarter 2016 Financial Results BEIJING, July 30, 2016 (GLOBE NEWSWIRE) -- eFuture Holding Inc. (Nasdaq:EFUT) (the “Company” or “eFuture”), a leading software and solution provider and a mobile business enabler to China's retail and consumer goods industries, today announced its unaudited financial results for the second quarter ended June 30, 2016. Second Quarter 201 6 Financial] [Form 6-K 001-33113 eFuture Holding Inc. Room A1103, A1105, A1106-07, Building A, Note: Note: eFuture Holding Inc. Kevin King Chairman 6-K 1 f6k_072916.htm FORM 6-K]
CO [China Cord Blood] 20-F: (Original Filing)
[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Peoples Republic of China Zhejiang Lukou Biotechnology Co., Ltd. Peoples Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,]
CHT [CHUNGHWA TELECOM CO] 6-K: (Original Filing)
[Chunghwa Telecom Reports Un-audited Consolidated Operating Results TAIPEI, Taiwan, R.O.C. July 28, 2016 Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) (Chunghwa or the Company) today reported its un-audited operating results for the second quarter of 2016. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards (Taiwan-IFRSs) on a consolidated basis. (Comparisons throughout the press release, unless] [FORM 6-K July 28, 2016 Chunghwa Telecom Co., Ltd. Room 110, Finance Department of Headquarters, 21-3 Hsinyi Road, Sec. 1, Taipei, Taiwan x x n/a Chunghwa Telecom Co., Ltd. Bo Yung Chen Chief Financial Officer Description 99.1 Press Release to Report Un-audited Consolidated Operating Results for the Second Quarter of 2016 6-K 1 htm_10372.htm LIVE FILING]
CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)
[CHINA YUCHAI INTERNATIONAL TO ANNOUNCE - Earnings Call to Begin at 8:00 A.M. EDT - Singapore, Singapore July 28, 2016 50566156 http://www.cyilimited.com For all other interested parties, a simultaneous webcast can be accessed at the investor relations section of the Companys website located at About China Yuchai International http://www.cyilimited.com China Yuchai International Limited, through its subsidiary, Guangxi Yuchai Machinery] [FORM 6-K July 28, 2016 China Yuchai International Limited 16 Raffles Quay #26-00 x x n/a China Yuchai International Limited Weng Ming Hoh President/Director Description 99.1 Press release dated July 28, 2016 - China Yuchai International to Announce Unaudited Second Quarter 2016 Financial Results on August 11 6-K 1 htm_10370.htm LIVE FILING]
IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: (Original Filing)
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By Shih-Jye Cheng Chairman & Chief Executive Officer Dear Stockholder, PROXY VOTE HAS NOT YET BEEN RECEIVED By now you should have received proxy materials in connection with the 2016 Annual General Meeting of Shareholders of ChipMOS TECHNOLOGIES (Bermuda) LTD. that is scheduled to be held August 12, 2016. According to our latest records, your PLEASE]
